Acumen Pharmaceuticals
ABOS
ABOS
66 hedge funds and large institutions have $179M invested in Acumen Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10.46% more ownership
Funds ownership: 64.17% → 74.63% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.21M
Holders
66
Holding in Top 10
2
Calls
$1.01M
Puts
$1.21M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$11.8M | |
| 3 | +$11.7M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$9.16M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.66M |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$1.41M | |
| 3 | -$473K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$303K |
| 5 |
D.E. Shaw & Co
New York
|
-$291K |